Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology : WJG - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology : WJG - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology : WJG - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology : WJG - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology : WJG - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology : WJG - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology : WJG - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research

Updates in therapeutic drug monitoring in inflammatory bowel disease
World J Gastroenterol. 2022 Jun 7;28(21):2282-2290. doi: 10.3748/wjg.v28.i21.2282.ABSTRACTBiologics and immunomodulators (IMM) are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn's disease. However, despite the efficacy of these therapies, many patients either have a primary lack of response or a secondary loss of response to these medications. Therapeutic drug monitoring (TDM) is a systematic approach to managing such patients. In this review, we summarize the latest data on TDM, including reactive and proactive TDM, in patients with inflammatory bowel disease on biologi...
Source: World Journal of Gastroenterology - July 8, 2022 Category: Gastroenterology Authors: Nilesh Lodhia Shanti Rao Source Type: research